Rising Rate of Infertility to Impel the Growth of In-Vitro Fertilization (IVF) Hormones Market in Future, according to Research Nester

“In Vitro Fertilization (IVF) Hormones Market: Global Demand Analysis & Opportunity Outlook 2021”

The global in vitro fertilization (IVF) hormones market is segmented into types such as follicle-stimulating hormone/ gonadotropin-releasing hormone (GnRH) and luteinizing hormone. Among these segments, follicle-stimulating hormone/ gonadotropin-releasing hormone (GnRH) segment is expected to occupy top position in overall in vitro fertilization (IVF) hormones market during the forecast period. Factors such as rising number of infertility cases, increasing awareness about infertility treatment, growth in per capita income of the population are expected to augment the growth of in vitro fertilization (IVF) hormones market.

Global in vitro fertilization (IVF) hormones market is expected to flourish at a CAGR of 10.1% over the forecast period. Moreover, the global in vitro fertilization (IVF) hormones market is anticipated to garner USD 7,571.2 Million by the end of 2021. Increasing number of infertility clinics across the globe and growing cases of infertility are some of the major factors behind the growth of in vitro fertilization (IVF) hormones market.

North America dominated the overall market of in vitro fertilization (IVF) hormones. According to Centers for Disease Control and Prevention, in U.S., 208,604 IVF procedures were performed, out of which, 70,354 infants were born. Additionally, rising success rate is expected to swell the demand for the In-Vitro fertilization hormone during the forecast period. Europe in vitro fertilization (IVF) hormones market is projected to grow at significant pace in the next few years. Asia Pacific is anticipated to witness a CAGR of 16.4% over the forecast period. Factors such as rising disposable income, growth in medical tourism and growing awareness regarding in vitro fertilization (IVF) treatment are likely to impel the growth of in vitro fertilization (IVF) hormones market.

Increasing Adoption of IVF Treatment across the Globe

Rising public awareness about infertility and its treatment has triggered the demand for in vitro fertilization (IVF) treatment. Moreover, as per human fertilisation and embryology authority, number of IVF cycles has witnessed an increase in the past few years. This factor is anticipated to foster the growth of in vitro fertilization (IVF) hormones market.

Free Report Sample Request @ https://www.researchnester.com/sample-request/2/rep-id-65

Rise in the Number of Infertility Clinics

The market is expected to escalate at a rapid pace during the forecast period on the account of the increasing number of infertility clinics across the world. Apart from this, high percentage of coupled facing infertility issue (around 15% of total population) is expected to surge the demand for In-vitro fertilization hormone (IVF) market over the next few years.
Although, high cost associated with IVF procedures (USD 10,000-12,000 per cycle) is likely to inhibit the growth of the global in vitro fertilization (IVF) hormones market in the near future.

The report titled “In Vitro Fertilization (IVF) Hormones Market: Global Demand Analysis & Opportunity Outlook 2021” delivers detailed overview of the global in vitro fertilization (IVF) hormones market in terms of market segmentation by type, by gender and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

Free Request Table of Contents Here: https://www.researchnester.com/toc-request/1/rep-id-65

This report also provides the existing competitive scenario of some of the key players of the global in vitro fertilization (IVF) hormones market which includes company profiling of Lee Biosolutions Inc., Aquatic Remedies Pvt. Ltd., Sigma-Aldrich, Empower Pharmacy, Kamiya Biomedical Company, Agilent Technologies, BBI solutions, Thermo Fisher Scientific Inc., Genzyme Corporation and Asta Medica GmbH. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global in vitro fertilization (IVF) hormones market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

For more info Ask The Analyst: https://www.researchnester.com/ask-the-analyst/rep-id-65

About Research Nester
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.

Contact for more Info:
Ajay Daniel
Email: ajay.daniel@researchnester.com
U.S. +1 646 586 9123
U.K. +44 203 608 5919

This release was published on openPR.